Nachrichten zur Flexion Therapeutics Aktie

Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript

FLXN earnings call for the period ending March 31, 2021....…

Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics?

NEW YORK, April 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TV, PHUN, IBRX, FLXN, and FOLD. To…

Flexion Therapeutics trades high on Q1 prelim revenue, FY21 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Flexion Therapeutics Inc: 8-K Report

8-K...…

Flexion Therapeutics Announces Preliminary First-Quarter 2021 Revenue and Provides Financial Guidance for 2021

BURLINGTON, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced preliminary ZILRETTA (triamcinolone acetonide…

Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare Conference

BURLINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D.,…

Flexion Therapeutics Inc: 8-K Report

8-K...…

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass., April 02, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to…

Flexion Therapeutics treats first patient in early-stage FX301 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Flexion Therapeutics Announces First Patient Treated in FX301 Phase 1b Trial for Management of Post-Operative Pain

BURLINGTON, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the treatment of the…

The Right Call On Frustrating Flexion Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Aspira extends gains as analysts weigh in; Flexion to benefit from Pfizer’s failure in osteoarthritis drug and more in today’s analyst action

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Flexion Therapeutics im Wert von 53.336$

Layman, Melissa - Vorstand - Tag der Transaktion: 2021-03-15...…

Flexion Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Flexion Therapeutics Inc (FLXN) Q4 2020 Earnings Call Transcript

FLXN earnings call for the period ending December 31, 2020....…

Flexion Therapeutics (FLXN) Reports Q4 Loss, Misses Revenue Estimates

Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of 9.09% and -1.09%, respectively, for the quarter ended December 2020. Do…

Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Flexion Therapeutics: Q4 Earnings Insights

Shares of Flexion Therapeutics (NASDAQ:FLXN) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up…

Flexion Therapeutics EPS beats by $0.10, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Flexion Therapeutics Inc: 8-K Report

8-K...…

Flexion Therapeutics Inc: 10-K Report

10-K...…

Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2020 Financial Results

BURLINGTON, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results and recent…

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to…

Will Flexion Therapeutics (FLXN) Report Negative Q4 Earnings? What You Should Know

Flexion Therapeutics (FLXN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on March 10, 2021

BURLINGTON, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report…

Flexion Therapeutics To Start Testing FX301 For Post-Op Pain In Patients After Musculoskeletal Surgery

The FDA signed off Flexion Therapeutics Incs&nbsp read more...…

Flexion Therapeutics Announces FDA Clearance of Investigational New Drug Application for FX301, a Novel Formulation of a Locally Administered NaV1.7 Inhibitor for Post-Operative Pain

BURLINGTON, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the U.S. Food and…

Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference

BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D.,…

FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With Eli Lilly

INDIANAPOLIS (dpa-AFX) - Todays Daily Dose brings you news about the progress in Flexion Therapeutics pipeline; Immunomes coronavirus research program;…

Flexion To Test Higher Dose Of FX201 Gene Therapy In Early-Stage Osteoarthritis Study

Q3 Report - 31 December 2020

Flexion reports another record-breaking quarter. Third quarter revenue up by 176% and gross profit increases by 223%. This is the…

National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®

- Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee…